Does taking L-Carnitine and Cadmium have an impact on gene expression of the liver tissues from rat models?

Authors

  • Duaa ABDULMOHSIN Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, Turkish Republic of Northern Cyprus.
  • Hakan AYTACOGLU Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, Turkish Republic of Northern Cyprus, Near East University, DESAM Research Institute, Nicosia, Nicosia, Turkish Republic of Northern Cyprus and Near East University, Center of Excellence, Genetics and Cancer Diagnosis-Research Center, Turkish Republic of Northern Cyprus. Hakan Aytacoglu
  • Gamze KOCAMAZ Near East University, Faculty of Medicine, Department of Histology and Embryology, Nicosia, Turkish Republic of Northern Cyprus. Gamze Kocamaz:
  • Aysel KUKNER Near East University, Faculty of Medicine, Department of Histology and Embryology, Nicosia, Turkish Republic of Northern Cyprus. Aysel Kukner:
  • Pınar TULAY Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, Turkish Republic of Northern Cyprus, Near East University, DESAM Research Institute, Nicosia, Nicosia, Turkish Republic of Northern Cyprus and Near East University, Center of Excellence, Genetics and Cancer Diagnosis-Research Center, Turkish Republic of Northern Cyprus. Pınar Tulay

DOI:

https://doi.org/10.3329/bjms.v24i2.81728

Keywords:

Cadmium; Gene expression; L-carnitine; Liver; mTOR pathway

Abstract

Objective The levels of increased reactive oxygen species (ROS) in presence of liver disorder might enhance lipid membrane peroxidation as well as manufacturing of inflammatory molecules, concluding in cellular damage and death. Cadmium is known to promote body’s ROS production leading to liver damage. L-Carnitine may lower oxidative stress, decrease inflammation, and increase antioxidant enzymes. ROS alters protein transcription and affects the mTOR network signaling. This study, therefore, investigated expression levels of important members of this pathway, mTOR, Akt1, and Akt2, in liver tissues obtained from rats treated with cadmium and L-Carnitine. Materials and methods Four distinct experimental groups were formed comprising of a total of 24 female rats that were administrated with the subsequent treatments orally for a period of 28 days. Cadmium was given to the first group at a dose of 2 mg/kg twice a week. The second group was provided with the same dose of cadmium as the previous group in conjunction with L-Carnitine 75 mg/kg daily. The third group was presented with L-Carnitine 75 mg/ kg every day. Finally, the fourth group constituted the control group. Rats were euthanised to obtain liver samples and RNA was isolated to provide the template for cDNA synthesis. Results and Discussion The results displayed that there was no statistical significance in the difference between the expression levels of mTOR, Akt1, and Akt2 among the control and study groups, respectively. This study showed that, administration of cadmium and L-Carnitine does not influence the activity levels of key mTOR pathway genes. Further studies will include expression analysis of other organs such as kidneys to investigate the interactions among cadmium and L-carnitine administration.

Bangladesh Journal of Medical Science Vol. 24 No. 02 April’25 Page : 614-620                              

Downloads

Abstract
62
PDF
60

Downloads

Published

2025-05-17

How to Cite

ABDULMOHSIN, D., AYTACOGLU, H., KOCAMAZ, G., KUKNER, A., & TULAY, P. (2025). Does taking L-Carnitine and Cadmium have an impact on gene expression of the liver tissues from rat models?. Bangladesh Journal of Medical Science, 24(2), 614–620. https://doi.org/10.3329/bjms.v24i2.81728

Issue

Vol. 24 No. 2 (2025)

Section

Original Articles

License

Copyright (c) 2025 Duaa ABDULMOHSIN, Hakan AYTACOGLU, Gamze KOCAMAZ, Aysel KUKNER, Pınar TULAY

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.